Clinical trial
Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic…
NCT00133627 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00133627 |
|---|---|
| Title | Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis |
| Official title | Safety and Efficacy Comparison Ketotifen Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis |
| Lead sponsor | Novartis, Industry |
| Collaborators | Alcon Research Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Seasonal Allergic Conjunctivitis |
| Intervention type | Drug |
| Interventions | Ketotifen |
| Enrollment | 229 |
| Start date | Apr 1, 2005 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Aug 23, 2005 |
| Last update posted | Nov 17, 2011 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: